Literature DB >> 34091022

Nearly 80 systematic reviews were published each day: Observational study on trends in epidemiology and reporting over the years 2000-2019.

Falk Hoffmann1, Katharina Allers2, Tanja Rombey3, Jasmin Helbach2, Amrei Hoffmann2, Tim Mathes4, Dawid Pieper4.   

Abstract

BACKGROUND: Systematic reviews (SRs) are useful tools in synthesising the available evidence, but high numbers of overlapping SRs are also discussed in the context of research waste. Although it is often claimed that the number of SRs being published is increasing steadily, there are no precise data on that. We aimed to assess trends in the epidemiology and reporting of published SRs over the last 20 years.
METHODS: A retrospective observational study was conducted to identify potentially eligible SRs indexed in PubMed from 2000 to 2019. From all 572,871 records retrieved, we drew a simple random sample of 4,000. The PRISMA-P definition of SRs was applied to full texts and only SRs published in English were included. Characteristics were extracted by one reviewer, with a 20% sample verified by a second person.
RESULTS: A total of 1,132 SRs published in 710 different journals were included. The estimated number of SRs indexed in 2000 was 1,432 (95% CI: 547-2,317), 5,013 (95% CI: 3,375-6,650) in 2010 and 29,073 (95% CI: 25,445-32,702) in 2019. Transparent reporting of key items increased over the years. About 7 out of 10 named their article a SR (2000-2004: 41.9% and 2015-2019: 74.4%). In 2000-2004, 32.3% of SRs were based in the UK (0% in China), in 2015-2019 24.0% were from China and 10.8% from the UK. Nearly all articles from China (94.9%) conducted a meta-analysis (overall: 58.9%). Cochrane reviews (n = 84; 7.4%) less often imposed language restrictions, but often did not report the number of records and full texts screened and did not name their article a SR (22.6% vs. 73.4%).
CONCLUSIONS: We observed a more than 20-fold increase in the number of SRs indexed over the last 20 years. In 2019, this is equivalent to 80 SRs per day. Over time, SRs got more diverse in respect to journals, type of review, and country of corresponding authors. The high proportion of meta-analyses from China needs further investigation. STUDY REGISTRATION: Open Science Framework (https://osf.io/pxjrv/).
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Keywords:  Cochrane Review; Evidence-Based Practice; Meta-Analysis; Reporting; Systematic Review; Trends

Year:  2021        PMID: 34091022     DOI: 10.1016/j.jclinepi.2021.05.022

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Red for danger in systematic reviews?

Authors:  Andrew Moore
Journal:  Eur J Hosp Pharm       Date:  2021-10-06

2.  Mitigating Disputes Originated by Multiple Discordant Systematic Reviews and Meta-Analyses: A Survey of Methodologists and Clinicians.

Authors:  Livia Puljak; Elena Parmelli; Matteo Capobussi; Marien Gonzalez-Lorenzo; Alessandro Squizzato; Lorenzo Moja; Nicoletta Riva
Journal:  Front Res Metr Anal       Date:  2022-04-15

3.  Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.

Authors:  Michelle Gates; Allison Gates; Dawid Pieper; Ricardo M Fernandes; Andrea C Tricco; David Moher; Sue E Brennan; Tianjing Li; Michelle Pollock; Carole Lunny; Dino Sepúlveda; Joanne E McKenzie; Shannon D Scott; Karen A Robinson; Katja Matthias; Konstantinos I Bougioukas; Paolo Fusar-Poli; Penny Whiting; Stephana J Moss; Lisa Hartling
Journal:  BMJ       Date:  2022-08-09

4.  Restrictions and their reporting in systematic reviews of effectiveness: an observational study.

Authors:  Jasmin Helbach; Dawid Pieper; Tim Mathes; Tanja Rombey; Hajo Zeeb; Katharina Allers; Falk Hoffmann
Journal:  BMC Med Res Methodol       Date:  2022-08-20       Impact factor: 4.612

5.  Kanglaite (Coix Seed Extract) as Adjunctive Therapy in Cancer: Evidence Mapping Overview Based on Systematic Reviews With Meta-Analyses.

Authors:  Cuncun Lu; Shuilin Wu; Lixin Ke; Fumei Liu; Wenru Shang; Xiuxiu Deng; Yanli Huang; Qiang Zhang; Xin Cui; Alexios-Fotios A Mentis; Yanming Xie; Zhifei Wang
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

6.  The score after 10 years of registration of systematic review protocols.

Authors:  Kim van der Braak; Mona Ghannad; Claudia Orelio; Pauline Heus; Johanna A A Damen; René Spijker; Karen Robinson; Hans Lund; Lotty Hooft
Journal:  Syst Rev       Date:  2022-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.